Description
Aim7 30 XR Tablet contains Gliclazide, a sulfonylurea for type 2 diabetes management. This extended-release formulation provides once-daily dosing convenience for patients requiring glycemic control. Aim7 30 XR Tablet helps maintain glycemic control throughout the day. The product is available in extended-release tablet form for oral administration. Use the product according to the instructions provided on the packaging or as advised by a healthcare professional. Please read the product label carefully and follow all recommended precautions and warnings before using this medicine. Important Note: This information is for general product purposes only and is not intended as medical advice. Always consult a healthcare professional before use.
Reviews
There are no reviews yet.